1. [O2–16–02]: ACCEPTABILITY, USABILITY, VALIDITY AND SENSITIVITY OF COGNITION ASSESSED IN UNSUPERVISED SETTINGS. (1st July 2017) Authors: Maruff, Paul; Schembri, Adrian; Petersen, Ronald C.; Aisen, Paul S.; Weiner, Michael; Albala, Bruce Journal: Alzheimer's & dementia Issue: Volume 13:Supplement 7S(2017)Part 12 Page Start: P596 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. [P1–043]: ELENBECESTAT, A NOVEL ORAL BACE INHIBITOR, HAS NO CLINICALLY MEANINGFUL EFFECT ON QTC INTERVAL UP TO A SUPRATHERAPEUTIC DOSE OF 200 MG. (1st July 2017) Authors: Lai, Robert YK.; Darpo, Borje; Dayal, Satish; Hall, Nancy; Chang, Min‐Kun; Albala, Bruce; Ferry, Jim; Rege, Bhaskar Journal: Alzheimer's & dementia Issue: Volume 13:Supplement 7S(2017)Part 5 Page Start: P250 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. [P2–003]: ELENBECESTAT PHARMACOKINETIC DRUG‐DRUG INTERACTIONS INDICATED NO DOSAGE ADJUSTMENTS REQUIRED FOR MOST CONCOMITANT TREATMENTS. (1st July 2017) Authors: Albala, Bruce; Lai, Robert YK.; Aluri, Jagadeesh; Boyd, Peter; Chang, Min‐Kun; Dayal, Satish; Ferry, Jim; Rege, Bhaskar Journal: Alzheimer's & dementia Issue: Volume 13:Supplement 7S(2017)Part 12 Page Start: P605 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. [P3–037]: PRECLINICAL STUDIES WITH ELENBECESTAT, A NOVEL BACE1 INHIBITOR, SHOW NO EVIDENCE OF HYPOPIGMENTATION. (1st July 2017) Authors: Moriyama, Tomoyuki; Fukushima, Tatsuto; Kokate, Tushar; Albala, Bruce Journal: Alzheimer's & dementia Issue: Volume 13:Supplement 7S(2017)Part 19 Page Start: P944 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Detecting cognitive changes in preclinical Alzheimer's disease: A review of its feasibility. Issue 4 (1st October 2016) Authors: Mortamais, Marion; Ash, Jessica A.; Harrison, John; Kaye, Jeffrey; Kramer, Joel; Randolph, Christopher; Pose, Carine; Albala, Bruce; Ropacki, Michael; Ritchie, Craig W.; Ritchie, Karen Journal: Alzheimer's & dementia Issue: Volume 13:Issue 4(2017) Page Start: 468 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. IC‐P‐040: EVALUATION OF TAU DEPOSITION IN AMYLOID POSITIVE MCI OR MILD‐AD DEMENTIA SUBJECTS FROM THE ELENBECESTAT MISSION AD PROGRAM USING [18 F]PI‐2620 PET. (1st July 2019) Authors: Stephens, Andrew Wills; Bullich, Santiago; Mueller, Andre; Berndt, Mathias; de Santi, Susan; Scott, David; Adamczuk, Kate; Suhy, Joyce; Kaplow, June; Krause, Stephen; Chang, Julia; Albala, Bruce; Luthman, Johan Journal: Alzheimer's & dementia Issue: Volume 15:Supplement 7S(2019)Part 1 Page Start: P45 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Increasing participant diversity in AD research: Plans for digital screening, blood testing, and a community‐engaged approach in the Alzheimer's Disease Neuroimaging Initiative 4. Issue 1 (9th October 2022) Authors: Weiner, Michael W.; Veitch, Dallas P.; Miller, Melanie J.; Aisen, Paul S.; Albala, Bruce; Beckett, Laurel A.; Green, Robert C.; Harvey, Danielle; Jack, Clifford R.; Jagust, William; Landau, Susan M.; Morris, John C.; Nosheny, Rachel; Okonkwo, Ozioma C.; Perrin, Richard J.; Petersen, Ronald C.; Ri... Journal: Alzheimer's & dementia Issue: Volume 19:Issue 1(2023) Page Start: 307 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. O4‐12‐05: EVALUATION OF TAU DEPOSITION IN AMYLOID‐POSITIVE MCI OR MILD AD DEMENTIA SUBJECTS FROM THE ELENBECESTAT MISSION AD PROGRAM USING [18 F]PI‐2620 PET. (1st July 2019) Authors: Stephens, Andrew Wills; Bullich, Santiago; Mueller, Andre; Berndt, Mathias; de Santi, Susan; Scott, David; Adamczuk, Kate; Suhy, Joyce; Kaplow, June; Krause, Stephen; Chang, Julia; Albala, Bruce; Luthman, Johan Journal: Alzheimer's & dementia Issue: Volume 15:Supplement 7S(2019)Part 24 Page Start: P1268 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. P1‐040: ELENBECESTAT, A NOVEL BACE INHIBITOR, DEMONSTRATES SIMILAR PHARMACOKINETICS AND TOLERABILITY IN JAPANESE SUBJECTS WITH MULTIPLE DOSINGS. (1st July 2006) Authors: Hayata, Nozomi; Yasuda, Sanae; Kanekiyo, Michiwo; Ito, Satoshi; Yoshida, Masayo; Kawaguchi, Hiroyuki; Lai, Robert YK.; Kaplow, June; Albala, Bruce; Luthman, Johan; Tsuno, Masanori Journal: Alzheimer's & dementia Issue: Volume 14:Supplement 7S(2018)Part 5 Page Start: P282 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. P1‐041: APOE4 STATUS AND AMYLOID BURDEN DIFFERENCES ACROSS REGIONS IN THE ELENBECESTAT MISSIONAD PHASE 3 PROGRAM. (1st July 2019) Authors: Roberts, Claire; Kanekiyo, Michio; Kaplow, June; Albala, Bruce Journal: Alzheimer's & dementia Issue: Volume 15:Supplement 7(2019)Part 4 Page Start: P248 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗